to make significant strides, in terms of
progressing proprietary product candidates into the clinic
Roots
Analysis has
announced the addition of “Human Microbiome Market, 2019-2030” report to its list
of offerings
The report features an in-depth analysis,
highlighting the diverse capabilities of stakeholders engaged in this domain.
In addition to other elements, the study includes:
§ A detailed assessment of the current market landscape of
microbiome therapeutics, providing information on drug / therapy developer(s).
§ Elaborate profiles of key players (established
after 2005) that are engaged in the development of microbiome therapeutics.
§ A detailed review of the current market
landscape of microbiome diagnostic tests, brief profiles of popular diagnostic
developers and indicative list of screening and profiling test kits.
§ A detailed assessment of the current market
landscape of FMT therapies, a geographical clinical trial analysis and information
on various stool banks.
§ A detailed business portfolio analysis based on
an attractiveness and competitiveness (AC) framework.
§ An analysis of the varied microbiome-focused
initiatives of big pharma players.
§ An analysis of the start-ups / small-sized
players engaged in the development of microbiome therapeutics and diagnostics.
§ An assessment of the most commonly targeted
therapeutic indications and details of microbiome-based drugs.
§ An analysis of the investments made at various
stages of development in start-ups / small-sized companies.
§ An indicative list of contract manufacturers, in-house
manufacturers and CROs that currently claim to have the necessary capabilities.
§ An assessment of the emerging role of big data highlighting
efforts focused on the development and implementation of various algorithms /
tools to analyze data generated from in the microbiome research.
§ An informative case study on the various other
applications of microbiome products, such as agriculture, animal health, plant
health, food products
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
segments:
§ Type
of Therapy (Tx)
§ Prescription
Drug
§ Prebiotics
§ Probiotics
§ Type
of Molecule (Tx)
§ Small
Molecules
§ Biologics
§ Target
Indication (Tx+Dx)
§ Acne
Vulgaris
§ Atopic
Dermatitis
§ Clostridium
difficile Infection
§ Colorectal
Cancer
§ Crohn’s
Disease
§ Diabetes
§ Irritable
Bowel Syndrome
§ Lactose
Intolerance
§ Lung
Cancer
§ Nonalcoholic
steatohepatitis (NASH)
§ Obesity
§ Ulcerative
colitis
§ Therapeutic
Area (Tx+Dx)
§ Autoimmune
Disorders
§ Dental
Disorders
§ Digestive
and Gastrointestinal Disorders
§ Dermatological
Disorders
§ Infectious
Disease
§ Metabolic
Disorders
§ Oncology
§ Others
§ Key
Geographical Regions (Tx+Dx)
§ North
America
§ Europe
§ Asia-Pacific
and Rest of the World
Key
companies covered in the report
§ 4D
Pharma
§ Armata
Pharmaceuticals
§ Evelo
Biosciences
§ Rebiotix
(Acquired by Ferring Pharmaceuticals)
§ Seres
Therapeutics
§ Vedanta
Biosciences
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or
email sales@rootsanalysis.com
Other Recent Offerings:
1.
Antibody Drug Conjugates Market (5th Edition), 2019-2030
2.
Gene Therapy Market (3rd
Edition), 2019 - 2030
3.
Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
4.
Synthetic Lethality-based Drugs and Targets Market, 2019-2030
About Roots Analysis
Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at
info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav
Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
